EraCal Therapeutics

📍 Schlieren, Switzerland🗓 Founded 2018👥 10 employees💰 Last funded Oct 2019
Biotechnology Research🌐 eracal.ch
Website LinkedIn
The biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in EraCal Therapeutics?
EraCal Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did EraCal Therapeutics last raise funding?
The most recent investment in EraCal Therapeutics recorded on gritt.io was in October 2019.
When was EraCal Therapeutics founded?
EraCal Therapeutics was founded in 2018.
What industry is EraCal Therapeutics in?
EraCal Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EraCal Therapeutics based?
EraCal Therapeutics is headquartered in Schlieren, Switzerland.